About the book
Novel technological, molecular, and immunologic approaches are rapidly creating novel insights into the biology and therapeutic perspectives of leukemias. The continuous and rather extensive influx of new information regarding the key features and underlying mechanisms as well as treatment options of leukemias requires frequent updating of this topic.
The primary objective of this book is to provide the specialists involved in the clinical management and experimental research of acute and chronic leukemias updates on the theoretical aspects as well as state-of-the-art diagnostic and clinical management of acute and chronic leukemias.
The book is intended to cover a broad spectrum of leukemia-related topics such as:
-novel and still evolving insights into the biology and diagnosis and how these result in new drug approvals and new therapeutic options with a focus on molecular and immunotherapeutic targeted therapeutics,
- the molecular and functional features of leukemic stem cells and their interaction with the microenvironment,
- preleukemic hematopoiesis and clonal diversity,
- new standard treatment algorithms,
- mechanisms of resistance and disease progression
- diagnosis and management of rare acute leukemia subtypes,
- Covid-19 aspects in specific leukemia categories,
- real-world data
- new drugs in development
